Gene-Disorder Association · Article
Gene
TYMSOSTYMS Opposite Strand RNA
×
First reported
1950
Supporting publications
1
Approved treatment annotated
Association Review
In brief
The association between TYMSOS (TYMS Opposite Strand RNA) and Osteogenic Sarcoma is reported, supported by a single source.
Sources
1
Clinical variants
0
Symptoms
21
Compounds
2
Trials
40of 2,680 via TYMSOS compounds
Publications
1
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
03
Osteogenic Sarcoma
The disorder
19 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
04
Phenotype
Clinical features
14 clinical features
The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.
Request access
05
Interventions
Therapeutics
2 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
06
Human studies
Clinical trials
2,680 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
1 publication
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
08
Provenance
References & sources
7 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access